EUSA Pharma

EUSA Pharma is a producer of treatments for rare diseases and oncology, with global operations spanning its UK headquarters and commercial operations in Europe and the US. EUSA Pharma has ambitious plans to expand its portfolio through acquisitions and licensing, led by an experienced management team with a strong track record in building successful specialty pharmaceutical companies. The business is backed by substantial funding from leading life sciences investor Essex Woodlands.